查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1792654

视网膜手术设备市场规模、份额、趋势及预测（按设备类型、应用、最终用途和地区），2025 年至 2033 年

Retinal Surgery Devices Market Size, Share, Trends and Forecast by Equipment Type, Application, End-Use, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球视网膜手术设备市场规模为 22 亿美元。展望未来， IMARC Group估计，到 2033 年，市场规模将达到 39 亿美元，2025-2033 年期间的复合年增长率为 6.3%。北美目前占据市场主导地位，到 2024 年将占据约 35% 的显着市场。随着人口老化和糖尿病病例增加，糖尿病视网膜病变和 AMD 等视网膜疾病的盛行率不断上升，推动了市场的发展。微创手术（如微切口玻璃体切除术）的技术进步提高了治疗效果。不断增长的医疗保健支出、新兴市场眼部保健服务的改善以及政府促进早期诊断的倡议进一步推动了需求。此外，不断增加的研发投入和创新设备的引进正在进一步扩大视网膜手术设备的市场份额。

市场受到老年黄斑部病变 (AMD)、糖尿病视网膜病变和视网膜剥离等视网膜疾病盛行率上升的推动。微创手术技术（例如微切口玻璃体切除术 (MIVS)）的技术进步提高了治疗效果和患者预后。此外，老年人口的成长更容易罹患视网膜疾病，这也刺激了市场需求。到 2080 年，全球 65 岁及以上人口预计将达到 22 亿，超过 18 岁以下儿童的数量，而 2080 年代全球人口峰值为 103 亿。预期寿命也在增加，从 2024 年的 73.3 岁增加到 2054 年的 77.4 岁，导致老年人口对眼保健服务的需求增加。老年人口结构的变化表明，迫切需要投资尖端视网膜手术技术，以改善全球快速成长的老年市场的视力健康。新兴经济体医疗保健支出的增加和先进眼科护理服务可近性的改善，进一步促进了视网膜手术设备市场的成长。政府的支持性措施以及人们对早期诊断和治疗意识的提高，也对市场扩张发挥重要作用。

美国是一个重要的区域市场，主要原因是慢性眼疾发生率不断上升，尤其是在老年人口中。超过 1,200 万 40 岁及以上的美国成年人患有视力障碍，其中包括 100 万人失明。预计到 2050 年，这一数字将增加一倍以上，主要原因是衰老和糖尿病等慢性疾病。视力障碍是美国成年人十大健康问题之一，其中 90% 的可预防失明病例是由糖尿病视网膜病变引起的。由于到 2050 年，视力障碍的经济成本可能达到 3,730 亿美元，因此对治疗此类无法避免的疾病的创新视网膜手术设备的需求很高。糖尿病病例的增加导致对糖尿病视网膜病变治疗的需求增加，而玻璃体切除系统和手术雷射的创新改善了手术效果。强大的医疗基础设施和主要行业参与者的存在推动了先进技术的快速应用。此外，患者意识的提高和主动筛检计划有助于早期发现疾病，从而改善手术干预。新设备的监管批准和製造商之间的策略合作进一步刺激了市场扩张，确保了尖端视网膜手术解决方案的稳定供应。

视网膜手术设备市场趋势：

眼部疾病盛行率上升

在全球范围内，视力相关疾病在人群中的盛行率不断上升，这是市场成长的主要催化剂。黄斑部病变、视网膜色素变性和糖尿病视网膜病变等疾病正变得越来越普遍，尤其是在全球糖尿病患者和老年人口中。此外，光是糖尿病视网膜病变就影响了全球25.2%的糖尿病患者，其中第1型糖尿病患者的发生率（约75%）显着高于第2型糖尿病患者的50%。根据视网膜手术设备市场预测，这些令人担忧的统计数据正在推动对有效且高效的手术解决方案的需求。需要精准治疗的病例数量的增加，导致视网膜手术设备的采用率不断提高，这些设备被认为具有成本效益高、省时省力、手术效率高的特点。随着全球糖尿病人口的成长，预计这一趋势将持续下去，从而支持市场扩张。为此，医疗保健提供者优先考虑早期诊断和先进的手术干预，以有效管理渐进性眼部疾病。

老年人口和年龄相关性视力丧失

全球人口老化是另一个显着因素，推动了视网膜手术设备市场的需求。老年人更容易患上与年龄相关的眼部疾病，例如白内障、青光眼和老花眼。白内障的盛行率就是一个明显的例子：在45-54岁的人群中，女性盛行率为4%，男性盛行率为2.4%，而75岁以上男性盛行率则大幅上升至30.49%和27.97%。随着全球人口老化，医疗保健产业对老年患者独特需求的先进手术干预措施的需求也随之增长。视网膜手术设备具有显着的优势，包括疼痛减轻、疤痕减少和恢復时间更快，对老年患者尤其具有吸引力。老年患者越来越容易患上慢性视力问题，促使医疗保健系统和设备製造商投资于能够改善治疗效果，同时确保老年人舒适和安全的技术。因此，这进一步创造了一个积极的视网膜手术设备市场前景。

技术进步和糖尿病发生率上升

微创手术工具和设备的技术进步正在极大地塑造视网膜手术设备市场的未来。同时，全球糖尿病病例的急剧增加也进一步催生了对专业眼科护理解决方案的需求。根据国际糖尿病联盟 (IDF) 的数据，目前全球近 5.89 亿成年人患有糖尿病，预计到 2050 年将上升到 8.53 亿。这种慢性疾病每年导致超过 340 万人死亡，是糖尿病视网膜病变和相关视力问题病例增加的主要原因。向微创手术的转变符合人们对更好的患者治疗效果、更快的康復和更强的安全性的更广泛追求。视网膜手术设备的创新在提供这些益处的同时，也满足了日益增长的糖尿病族群的独特医疗需求。随着全球对治疗方案的认识不断传播，技术创新与健康人口统计的融合正在推动市场成长。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球视网膜手术设备市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依设备类型

  • 玻璃体切除机
  • 视网膜雷射设备
  • 手术器械
    • 主要类型
      • 套管
      • 钳子
      • 切刀
      • 冷冻探针
      • 其他的

第七章：市场区隔：依应用

  • 糖尿病视网膜病变
  • 视网膜剥离
  • 其他的

第 8 章：市场区隔：最终用途别

  • 医院
  • 眼科诊所
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格指标

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alcon Management SA
    • Bausch & Lomb Incorporated
    • Carl Zeiss
    • Ellex Medical Lasers
    • Erbe Elektromedizin
    • Escalon Medicals
    • Iridex Corporation
    • Leica Microsystems GmbH
    • Lumenis
    • Nidek Co. Ltd.
    • Optos PLC
    • Second Sigh Medical Products
    • Synergetics USA Inc.
    • Topcon Corporation
Product Code: SR112025A2059

The global retinal surgery devices market size was valued at USD 2.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 3.9 Billion by 2033, exhibiting a CAGR of 6.3% during 2025-2033. North America currently dominates the market, holding a significant market share of around 35% in 2024. The market is driven by the rising prevalence of retinal disorders, including diabetic retinopathy and AMD, fueled by aging population and increasing diabetes cases. Technological advancements in minimally invasive surgeries, such as microincision vitrectomy, enhance treatment efficacy. Growing healthcare expenditure, improved access to eye care in emerging markets, and government initiatives promoting early diagnosis further propel demand. Additionally, increasing R&D investments and the introduction of innovative devices are further expanding the retinal surgery devices market share.

The market is driven by the rising prevalence of retinal disorders such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal detachment. Technological advancements in minimally invasive surgical techniques, such as microincision vitrectomy surgery (MIVS), enhance treatment efficacy and patient outcomes. Additionally, the growing geriatric population, which is more susceptible to retinal diseases, fuels market demand. By 2080, the global number of individuals aged 65 and above is expected to stand at 2.2 billion, outnumbering children under the age of 18, against a background of a peak global population of 10.3 billion in the 2080s. Life expectancy is also increasing, rising from 73.3 years in 2024 to 77.4 years in 2054, resulting in increased demand for eye care services among the elderly population. The changing demographics of the aging population indicate the urgent need for investment in cutting-edge retinal surgery technologies to improve vision health in the fast-growing geriatric markets around the world. Increased healthcare expenditure and improved access to advanced ophthalmic care in emerging economies further contribute to the retinal surgery devices market growth. Supportive government initiatives and increasing awareness about early diagnosis and treatment also play a significant role in expanding the market.

The United States stands out as a key regional market, primarily driven by the rising incidences of chronic eye conditions, particularly among the aging population. Over 12 million U.S. adults aged 40 and older have vision impairment, including 1 million who are blind. The number is estimated to more than double by the year 2050, mostly due to aging and chronic conditions such as diabetes. Vision disability ranks among the leading ten health problems in U.S. adults, with diabetic retinopathy causing 90% of cases of preventable blindness. Since the economic cost of vision impairment is likely to hit USD 373 Billion by 2050, demand for innovative retinal surgery equipment to treat such inescapable disorders is high. Increasing cases of diabetes contribute to higher demand for diabetic retinopathy treatments, while innovations in vitrectomy systems and surgical lasers improve procedural outcomes. Strong healthcare infrastructure and the presence of major industry players drive rapid adoption of advanced technologies. Additionally, heightened patient awareness and proactive screening programs facilitate early disease detection, improving surgical interventions. Regulatory approvals for novel devices and strategic collaborations among manufacturers further stimulate market expansion, ensuring a steady pipeline of cutting-edge retinal surgical solutions.

Retinal Surgery Devices Market Trends:

Rising Eye Disorder Prevalence

The increasing global prevalence of vision-related disorders among the masses is a major catalyst for growth in the market. Conditions such as macular degeneration, retinitis pigmentosa, and diabetic retinopathy are becoming more widespread, especially among diabetic and aging populations across the globe. Along with this, diabetic retinopathy alone affects 25.2% of individuals living with diabetes worldwide, with a significantly higher occurrence in type 1 diabetics (approximately 75%) compared to 50% in type 2 diabetics. According to the retinal surgery devices market forecast, these alarming statistics are pushing the demand for effective and efficient surgical solutions. The rise in cases requiring precise treatment is leading to increased adoption of retinal surgery devices, which are considered cost-effective, time-saving, and highly efficient during procedures. With a growing global diabetic population, this trend is expected to persist, supporting market expansion. In response, healthcare providers are prioritizing early diagnosis and advanced surgical interventions to manage progressive eye diseases effectively.

Geriatric Population and Age-Related Vision Loss

The aging demographic worldwide is another prominent factor enhancing the retinal surgery devices market demand. Elderly individuals are more susceptible to age-related ocular diseases such as cataracts, glaucoma, and presbyopia. Cataract prevalence provides a clear example: among individuals aged 45-54, the condition affects 4% of females and 2.4% of males, which dramatically increases to 30.49% in females and 27.97% in males aged 75 and above. As the global population continues to age, the healthcare sector is experiencing a corresponding rise in the need for advanced surgical interventions tailored to the unique requirements of older patients. Retinal surgery devices offer significant benefits, including less pain, minimal scarring, and quicker recovery times, which are particularly appealing for geriatric patients. This demography's growing vulnerability to chronic vision issues is encouraging healthcare systems and device manufacturers to invest in technologies that improve outcomes while ensuring comfort and safety for older individuals. Therefore, this is further creating a positive retinal surgery devices market outlook.

Technological Advancements and Rising Diabetes Incidence

Technological progress in minimally invasive surgical tools and equipment is significantly shaping the future of the retinal surgery devices market. Simultaneously, the steep rise in global diabetes cases is creating further demand for specialized eye care solutions. According to the International Diabetes Federation (IDF), nearly 589 million adults currently live with diabetes, a number projected to rise to 853 million by 2050. This chronic condition contributes to more than 3.4 million deaths each year and is a key driver behind the increasing cases of diabetic retinopathy and related vision issues. The shift towards minimally invasive surgeries aligns with the broader push for better patient outcomes, faster recovery, and enhanced safety. Innovations in retinal surgery devices are offering these benefits while catering to the growing diabetic population's unique medical needs. As awareness of treatment options spreads globally, this convergence of technological innovation and health demographics is propelling market growth.

Retinal Surgery Devices Industry Segmentation:

Analysis by Equipment Type:

  • Vitrectomy Machines
  • Retinal Laser Equipment
  • Surgical Instruments
    • Cannulas
    • Forceps
    • Cutters
    • Cryoprobes
    • Others

Vitrectomy machines stand as the largest component in 2024, holding around 44.8% of the market, driven by their critical role in treating complex retinal conditions, such as diabetic retinopathy, retinal detachment, and macular holes. These advanced systems enable precise removal of vitreous gel and scar tissue while minimizing trauma to surrounding structures, improving surgical outcomes. According to the retinal surgery devices market research report, the shift toward minimally invasive vitrectomy surgery (MIVS) with smaller-gauge instruments has further increased adoption, reducing recovery times and complications. Technological advancements, including high-speed cutters, integrated fluidics, and enhanced visualization systems, enhance surgical efficiency and safety. Additionally, the rising prevalence of retinal diseases, an aging population, and increasing diabetic cases contribute to sustained demand. Leading manufacturers continue to innovate, introducing portable and user-friendly systems that expand accessibility in both hospitals and ambulatory surgical centers. With superior efficacy and expanding applications, vitrectomy machines remain indispensable in retinal surgery, securing their position as the leading equipment type in the market.

Analysis by Application:

  • Diabetic Retinopathy
  • Retinal Detachment
  • Others

Diabetic retinopathy leads the market with around 40.6% of market share in 2024, primarily due to the escalating global prevalence of diabetes and its associated ocular complications. As a leading cause of vision loss among working-age adults, this progressive condition demands advanced surgical interventions such as vitrectomy and laser photocoagulation to manage vitreous hemorrhages, retinal detachment, and macular edema. The growing diabetic population, coupled with poor glycemic control in many patients, fuels the need for early and aggressive treatment, driving demand for specialized retinal surgery devices. Additionally, increasing awareness about diabetes-related eye complications and improved screening programs have led to earlier diagnosis, expanding the patient pool requiring surgical care. Technological advancements in imaging and microsurgical tools further enhance treatment precision, supporting segment growth. With diabetes rates continuing to rise worldwide, particularly in aging populations, diabetic retinopathy is expected to maintain its dominance as the key application driving the retinal surgery devices market.

Analysis by End-Use:

  • Hospitals
  • Ophthalmology Clinics
  • Others

Hospitals lead the market with around 60.1% of market share in 2024, due to their advanced infrastructure, availability of skilled ophthalmologists, and ability to handle complex retinal procedures. Equipped with state-of-the-art operating rooms and diagnostic tools, hospitals are the primary settings for vitrectomies, retinal detachment repairs, and other intricate eye surgeries. The increasing prevalence of retinal disorders, coupled with rising hospital admissions for vision-related conditions, further drives demand in this segment. Additionally, hospitals often serve as referral centers for specialized ophthalmic care, attracting patients requiring advanced surgical interventions. The growing adoption of minimally invasive retinal surgeries in hospital settings, supported by favorable reimbursement policies, also contributes to segment dominance. With continuous investments in healthcare infrastructure and the integration of cutting-edge surgical technologies, hospitals remain the preferred choice for retinal treatments, reinforcing their position as the leading end-use segment in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 35%, driven by advanced healthcare infrastructure, high adoption of innovative surgical technologies, and a significant patient pool suffering from retinal disorders. The region's leadership is reinforced by the rising prevalence of diabetes and age-related macular degeneration (AMD), increasing demand for vitrectomy and other retinal procedures. Well-established reimbursement policies, particularly in the U.S., enhance patient access to advanced treatments, while strong R&D investments by key industry players accelerate product development. Additionally, the presence of leading ophthalmic centers and skilled surgeons supports the adoption of cutting-edge devices. High awareness about retinal health and proactive screening programs further contribute to early diagnosis and surgical intervention. With continuous technological advancements and favorable regulatory frameworks, North America remains the largest and most influential regional segment in the global retinal surgery devices market.

Key Regional Takeaways:

United States Retinal Surgery Devices Market Analysis

In 2024, the US accounted for around 85.80% of the total North America retinal surgery devices market. The United States market is primarily driven by the increasing prevalence of retinal disorders, including age-related macular degeneration (AMD) and diabetic retinopathy. According to the CDC, in 2021, approximately 9.6 million individuals in the United States were affected by diabetic retinopathy (DR). Among them, 1.84 million were experiencing vision-threatening forms of DR. In line with this, continual advancements in retinal imaging and diagnostic technologies, enabling earlier detection and more accurate treatment of retinal conditions, are propelling market growth. Furthermore, the rising aging population, which is more susceptible to retinal diseases, is contributing to market demand. Additionally, the growing adoption of minimally invasive procedures, with these techniques offering quicker recovery times and reduced risks, is driving the market expansion. The enhanced surgical outcomes facilitated by innovations in retinal surgery devices, such as improved lasers and surgical microscopes, are stimulating market appeal. Similarly, the increased awareness of retinal diseases and advancements in personalized medicine are expanding the market scope. Moreover, favorable reimbursement policies and government initiatives promoting eye health are creating lucrative opportunities in the market.

Europe Retinal Surgery Devices Market Analysis

The market in Europe is experiencing growth due to increasing geriatric population leading to a higher prevalence of age-related macular degeneration and diabetic retinopathy. As per an industry report, in Europe, age-related macular degeneration (AMD) affects about 67 million individuals, projected to reach 77 million by 2050. Prevalence rises from 5% in ages 55-64 to 17.4% in those over 85, with 1.4 late-stage AMD cases per 1,000 individuals aged 60+, annually. Similarly, enhanced reimbursement policies in key European countries are making retinal procedures more accessible in the market. The growing adoption of minimally invasive vitreoretinal surgery techniques fueling the need for precision instruments, is fostering market expansion. Furthermore, continuous innovation by European manufacturers in micro-incision and illumination technologies is accelerating higher product uptake. The rising awareness campaigns and proactive screening initiatives improving early diagnosis rates are enhancing market appeal. Additionally, the expansion of ophthalmology training programs contributing to a skilled workforce, enabling the safe use of complex devices, is bolstering market development. Besides this, numerous cross-border healthcare collaborations and harmonized regulatory frameworks within the EU encouraging product approvals and regional distribution, are providing an impetus to the market.

Asia Pacific Retinal Surgery Devices Market Analysis

The Asia Pacific market is being propelled by the changing lifestyles, rising diabetes rates, and increasing diabetic retinopathy cases. According to NCBI, the number of individuals with diabetes in India rose sharply from 33 million in 2000 to 72 million in 2021 and is expected to reach 125 million by 2045. In accordance with this, rising investments in public and private healthcare infrastructure, improving access to advanced ophthalmic procedures, are supporting market expansion. The increasing presence of a large patient pool and rising disposable incomes is increasing the affordability and demand in the market. Furthermore, the expansion of medical tourism across Southeast Asia, heightening the requirement for cutting-edge retinal surgical technologies, is a significant market driver. Additionally, the growing presence of device makers in the region, augmenting access to innovative retinal surgery tools suited to local needs, is impelling the market. Moreover, favorable government-led health initiatives in countries including India and China, promoting eye health awareness and early detection, are impacting the market dynamics.

Latin America Retinal Surgery Devices Market Analysis

In Latin America, the market is advancing due to increasing rates of chronic eye conditions such as retinal detachment and macular holes, particularly in aging populations. Furthermore, various government-led efforts to expand universal healthcare coverage are enhancing access to ophthalmic surgeries in the market. As per NCBI, 14.14% of the population in Latin America suffers from moderate to severe vision impairment and blindness. Blindness is most prevalent in Tropical Latin America at 3.89%, and least in Southern Latin America at 0.96%. The rising awareness about preventable blindness fostering early diagnosis and timely interventions, is propelling the market growth. In addition to this, numerous regional partnerships with global manufacturers are driving advanced surgical tech and training adoption, augmenting outcomes in public and private care.

Middle East and Africa Retinal Surgery Devices Market Analysis

The market in the Middle East and Africa is significantly progressing attributed to the growing burden of inherited retinal disorders. Similarly, increasing penetration of vision care services in underserved rural areas, expanding the treatment base, is impelling development in the market. Furthermore, the rising prevalence of hypertension and lifestyle-related conditions is leading to a rise in retinal vascular complications is driving the need for precision retinal surgery tools and advanced diagnostic equipment, thereby expanding market reach. According to NCBI, hypertension affects approximately 36% of the general population in the African region. Apart from this, strategic collaborations with international ophthalmic organizations, enhancing clinical training and knowledge transfer, are influencing the market dynamics.

Competitive Landscape:

The competitive landscape of the market is characterized by intense rivalry among key players striving to strengthen their market position. Companies are focusing on technological advancements, launching next-generation devices with enhanced precision, efficiency, and minimally invasive capabilities. Strategic collaborations, mergers, and acquisitions are common as firms aim to expand their product portfolios and geographic reach. Investments in research and development are prioritized to introduce innovative solutions for complex retinal conditions. Additionally, players are emphasizing regulatory approvals and clinical validations to ensure product efficacy and safety. Marketing strategies include educational initiatives to raise awareness among healthcare professionals, while competitive pricing and after-sales support further drive adoption. The market also sees a growing emphasis on portable and user-friendly systems to cater to diverse clinical settings, reinforcing competition.

The report provides a comprehensive analysis of the competitive landscape in the retinal surgery devices market with detailed profiles of all major companies, including:

  • Alcon Management S. A.
  • Bausch & Lomb Incorporated
  • Carl Zeiss
  • Ellex Medical Lasers
  • Erbe Elektromedizin
  • Escalon Medicals
  • Iridex Corporation
  • Leica Microsystems GmbH
  • Lumenis
  • Nidek Co. Ltd.
  • Optos PLC
  • Second Sigh Medical Products
  • Synergetics USA Inc.
  • Topcon Corporation

Key Questions Answered in This Report

  • 1.How big is the retinal surgery devices market?
  • 2.What is the future outlook of the retinal surgery devices market?
  • 3.What are the key factors driving the retinal surgery devices market?
  • 4.Which region accounts for the largest retinal surgery devices market share?
  • 5.Which are the leading companies in the global retinal surgery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Retinal Surgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Equipment Type

  • 6.1 Vitrectomy Machines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Retinal Laser Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Surgical Instruments
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Cannulas
      • 6.3.2.2 Forceps
      • 6.3.2.3 Cutters
      • 6.3.2.4 Cryoprobes
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Diabetic Retinopathy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retinal Detachment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ophthalmology Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Alcon Management S. A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bausch & Lomb Incorporated
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Carl Zeiss
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ellex Medical Lasers
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Erbe Elektromedizin
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Escalon Medicals
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Iridex Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Leica Microsystems GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Lumenis
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Nidek Co. Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Optos PLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Second Sigh Medical Products
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Synergetics USA Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
    • 14.3.14 Topcon Corporation
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials

List of Figures

  • Figure 1: Global: Retinal Surgery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Retinal Surgery Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Retinal Surgery Devices Market: Breakup by Equipment Type (in %), 2024
  • Figure 4: Global: Retinal Surgery Devices Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Retinal Surgery Devices Market: Breakup by End-Use (in %), 2024
  • Figure 6: Global: Retinal Surgery Devices Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Retinal Surgery Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Retinal Surgery Devices (Vitrectomy Machines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Retinal Surgery Devices (Vitrectomy Machines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Retinal Surgery Devices (Surgical Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Retinal Surgery Devices (Surgical Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Retinal Surgery Devices (Retinal Detachment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Retinal Surgery Devices (Retinal Detachment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Retinal Surgery Devices (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Retinal Surgery Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Retinal Surgery Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Retinal Surgery Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Retinal Surgery Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Retinal Surgery Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia Pacific: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia Pacific: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Global: Retinal Surgery Devices Industry: SWOT Analysis
  • Figure 75: Global: Retinal Surgery Devices Industry: Value Chain Analysis
  • Figure 76: Global: Retinal Surgery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Retinal Surgery Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Retinal Surgery Devices Market Forecast: Breakup by Equipment Type (in Million USD), 2025-2033
  • Table 3: Global: Retinal Surgery Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Retinal Surgery Devices Market Forecast: Breakup by End-Use (in Million USD), 2025-2033
  • Table 5: Global: Retinal Surgery Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Retinal Surgery Devices Market: Competitive Structure
  • Table 7: Global: Retinal Surgery Devices Market: Key Players